The only positive in best term, until and if any revised bid is made, is confirmation pathology and imaging are performing strongly in this environment, which very few other businesses can claim, evidence of the environment being very favourable for Healius.
Ann: Update on non-binding indicative acquisition proposal, page-2
Add HLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.38 |
Change
0.045(3.38%) |
Mkt cap ! $998.3M | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.38 | $1.33 | $3.765M | 2.758M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 37 | 146122 | $1.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.38 | 37960 | 1 |
View Market Depth
| Last trade - 16.10pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.37 |
Change
0.045 ( 3.10 %) |
||||
| Open | High | Low | Volume | ||
| $1.34 | $1.38 | $1.33 | 1791362 | ||
| Last updated 15.59pm 06/06/2024 ? | |||||
| HLS (ASX) Chart |